Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mineralocorticoid receptor antagonist for intradialytic hypertension
TCTR20200604013Phase 3Completed
- Sponsor
- Lampang Hospital
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of canrenoic acid in Intradialytic hypertension (IDH), sponsored by Lampang Hospital. Started Jan 2021; status: completed.
02
Drugs
canrenoic acid
03
Conditions
Intradialytic hypertension (IDH)
Beyond the preview
Go deeper on TCTR20200604013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200604013.